Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment

被引:72
作者
Ullah, Asmat [1 ]
Ullah, Najeeb [2 ]
Nawaz, Touseef [3 ]
Aziz, Tariq [4 ]
机构
[1] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Pharm, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Biochem & Mol Biol, Xian 710061, Shaanxi, Peoples R China
[3] Gomal Univ, Fac Pharm, Dera Ismail Khan, Pakistan
[4] Westlake Univ, Sch Engn, Hangzhou 310024, Zhejiang, Peoples R China
关键词
Sanguinarine; cancer; natural agent; nanoparticle; molecular target; chemo-preventive effects; CIRCULATING TUMOR-CELLS; BENZOPHENANTHRIDINE ALKALOID SANGUINARINE; PLANT SECONDARY METABOLITES; NF-KAPPA-B; INDUCED APOPTOSIS; INHIBITS GROWTH; BREAST-CANCER; IN-VITRO; MESENCHYMAL TRANSITION; INDUCED ACTIVATION;
D O I
10.2174/1871520622666220831124321
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Historically, natural plant-derived drugs received a great impact of consideration in the treatment of several human-associated disorders. Cancer is a devastating disease and the second most cause of mortality. Sanguinarine (SANG), a naturally isolated plant alkaloidal agent, possesses chemo-preventive effects. Several studies have revealed that SANG impedes tumor metastasis and development by disrupting a wide range of cell signaling pathways and its molecular targets, such as BCL-2, MAPKs, Akt, NF-kappa B, ROS, and microRNAs (miRNAs). However, its low chemical stability and poor oral bioavailability remain key issues in its use as a medicinal molecule. A novel method (e.g., liposomes, nanoparticles, and micelles) and alternative analogs provide an exciting approach to alleviate these problems and broaden its pharmacokinetic profile. Cancer-specific miRNA expression is synchronized by SANG, which has also been uncertain. In this critical study, we review the utilization of SANG mimics and nano-technologies to improve its support in cancer. We focus on recently disclosed studies on SANG anti-cancer properties.
引用
收藏
页码:765 / 778
页数:14
相关论文
共 149 条
[1]   10-year update on chemotherapy for non-small cell lung cancer [J].
Abratt, R. P. ;
Hart, G. J. .
ANNALS OF ONCOLOGY, 2006, 17 :V33-V36
[2]   Anticancer potential of sanguinarine for various human malignancies [J].
Achkar, Iman W. ;
Mraiche, Fatima ;
Mohammad, Ramzi M. ;
Uddin, Shahab .
FUTURE MEDICINAL CHEMISTRY, 2017, 9 (09) :933-950
[3]  
Ahmad N, 2000, CLIN CANCER RES, V6, P1524
[4]   Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling [J].
Akhtar, Sabah ;
Achkar, Iman W. ;
Siveen, Kodappully S. ;
Kuttikrishnan, Shilpa ;
Prabhu, Kirti S. ;
Khan, Abdul Q. ;
Ahmed, Eiman, I ;
Sahir, Fairooz ;
Jerobin, Jayakumar ;
Raza, Afsheen ;
Merhi, Maysaloun ;
Elsabah, Hesham M. ;
Taha, Ruba ;
El Omri, Halima ;
Zayed, Hatem ;
Dermime, Said ;
Steinhoff, Martin ;
Uddin, Shahab .
FRONTIERS IN ONCOLOGY, 2019, 9
[5]   Antitumor Potential of Berberine and Cinnamic Acid Against Solid Ehrlich Carcinoma in Mice [J].
Almeer, Rafa S. ;
Aref, Ahmed M. ;
Hussein, Romisa A. ;
Othman, Mohamed S. ;
Moneim, Ahmed E. Abdel .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (03) :356-364
[6]   Immunohistochemical assessment of Viadent®-associated leukoplakia [J].
Anderson, KM ;
Stoner, GD ;
Fieds, HW ;
Chacon, GE ;
Dohar, AL ;
Gregg, BR ;
Mallery, SR .
ORAL ONCOLOGY, 2005, 41 (02) :200-207
[7]   In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice [J].
Ansari, KM ;
Dhawan, A ;
Khanna, SK ;
Das, M .
FOOD AND CHEMICAL TOXICOLOGY, 2005, 43 (01) :147-153
[8]   Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines [J].
Baharuddin, Puteri ;
Satar, Nazilah ;
Fakiruddin, Kamal Shaik ;
Zakaria, Norashikin ;
Lim, Moon Nian ;
Yusoff, Narazah Mohd ;
Zakaria, Zubaidah ;
Yahaya, Badrul Hisham .
ONCOLOGY REPORTS, 2016, 35 (01) :13-25
[9]   The natural compound sanguinarine perturbs the regenerative capabilities of planarians [J].
Balestrini, Linda ;
Di Donfrancesco, Alessia ;
Rossi, Leonardo ;
Marracci, Silvia ;
Isolani, Maria E. ;
Bianucci, Anna M. ;
Batistoni, Renata .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 2017, 61 (1-2) :43-52
[10]  
BERENBAUM MC, 1989, PHARMACOL REV, V41, P93